Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05301140 · ClinicalTrials.gov registry record
Vivistim Registry for Paired VNS Therapy (GRASP)
A clinical trial of Upper Extremity Problem, sponsored by MicroTransponder.
- Recruiting
- Registry status
- 1,000
- Enrollment target
- 2
- Study locations
NCT05301140: Recruiting study of Upper Extremity Problem, sponsored by MicroTransponder.
NCT05301140 is a study of Upper Extremity Problem that is actively recruiting participants, run by MicroTransponder. The registered enrollment target is 1,000 participants. The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05301140, a study of Upper Extremity Problem, is actively recruiting participants, sponsored by MicroTransponder.
- RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout the therapy process. Physicians or sites will receive appropriate remuneration for the effort and cost involved in collecting and transmitting this data to MicroTransponder Inc.
Primary Outcome
Change in Fugl Meyer Assessment score
Conditions Studied
Interventions
- DEVICE Vivistim System
Study Locations (2)
New York
- Mt. Sinai - New York
Pennsylvania
- Thomas Jefferson - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2023-03-15 |
| Est. Completion | 2028-12-31 |
What NCT05301140 shows while recruiting
NCT05301140 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Upper Extremity Problem appearing as the primary indexed condition, and to 1 intervention - of which Vivistim System is the first listed.
NCT05301140 reports a single indexed study location in New York, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05301140 about?
NCT05301140 is a clinical study titled "Vivistim Registry for Paired VNS Therapy (GRASP)". The purpose of the Vivistim Registry for Paired VNS Therapy (GRASP) is to gather real-world information on patients with arm and hand deficits post-stroke who are considering Vivistim System treatment. Before and after Vivistim System implant, patient data will be collected and reported throughout t...
What is the current status of trial NCT05301140?
This trial is currently recruiting. The enrollment target is 1,000 participants. The study started on 2023-03-15. Estimated completion is 2028-12-31.
What conditions does trial NCT05301140 study?
This clinical trial studies the following conditions: Upper Extremity Problem.
What interventions are being tested in trial NCT05301140?
The interventions under investigation include: Vivistim System (DEVICE).
Who is sponsoring clinical trial NCT05301140?
This trial is sponsored by MicroTransponder, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05301140 being conducted?
This trial has 2 study locations across New York, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Upper Extremity Problem
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI